Directly Compressible Excipients Explained: How NOVOPOWER Simplifies Tablet Manufacturing
In pharma, complexity is often the biggest enemy of efficiency. Novo Excipients, as a customer-first excipient manufacturing company, continuously innovates tablet manufacturing solutions that simplify pharmaceutical processes. NovoPower is a clear example of this approach.
In this blog, we have explained how NovoPower can actually simplify your manufacturing process. To understand this properly, first let us understand direct compression.
What is Direct Compression?
Direct Compression is the simplest, quickest, and most economical method for tablet manufacturing. Usually, tablet manufacturing involves wet or dry granulation. However, direct compression doesn’t require granulation. High-quality excipients actually make or break this method.
Why High-Quality Directly Compressible Excipients are Important?
Directly compressible excipients are specially processed excipients that allow tablet production without additional steps of granulation.
A suitable tablet manufacturing excipient for direct compression must provide:
- Good Flowability
- Excellent Compressibility
- Uniform API Distribution
- Mechanical Strength
If high-quality excipients are not used in the process, it may lead to fragile tablets and uniformity failures. Novo Excipient has created a unique in-formulation that has made this approach even more reliable and scalable.
What is Novo-Power, and how is it Different from Other Directly Compressible Excipients?
Novo-Power is a specially engineered, high-quality, direct compression excipient, manufactured under strict cGMP and WHO standards at Novo Excipient’s FDA-approved facility.
It is an excipient blend, meaning it has diluents, binders, anti-adherents, lubricants, and disintegrants. While many directly compressible excipients lower the need for wet granulation, there are still certain dry blending steps involved.
NovoPower optimizes even this process. It combines functional properties into a single excipient system, allowing tablets to be manufactured with even fewer steps.
How NovoPower Simplifies Tablet Manufacturing?
- Fewer Processing Steps:
As a direct compression excipient, it completely eliminates granulation, drying, and milling. It combines diluents, binders, anti-adherents, lubricants, and disintegrants into a single excipient. It even minimizes dry mixing requirements and enables faster, more predictable compression.
- Reduced Equipment Dependency:
With fewer steps, there are fewer machines to be used and less hassle of cleaning and validation.
- Reduces Risk of Drug Damage:
With the fewest processes, the materials stay exposed for a very short amount of time, reducing the chance of contamination. It also eliminates the hazardous steps of non-aqueous granulation. Moreover, since moisture, external chemicals, or heat are not required, there is less risk of drug property change or microbial growth.
- Faster Scale-up:
NovoPower helps ensure process consistency, even during scale-up. It supports easy tech transfer and better scaling from lab to commercial batches. Compared to conventional methods, with a direct compression excipient blend, you also geta higher yield.
- Lower Risk of Variability:
NovoPower is a blend of various tablet manufacturing excipients. So there are fewer raw materials required during the tablet manufacturing process. Hence, there is less risk of batch-to-batch variations.
Moreover, manufactured through a controlled process, it delivers a uniform and homogeneous blend with excellent flow and high compressibility. This results in consistent tablet weight, reduced content variability, and fewer manufacturing rejections.
- Simplified Documentation:
Fewer steps mean less validation, fewer records, and easier regulatory justifications. This is especially valuable for companies operating in regulated and emerging markets.
- Reduced Cost, Time, and Manpower:
Since the steps are reduced, time and manpower are automatically saved. Moreover, fewer machine setup, reduced process variability, a single inventor,y and lower risk of drug damage makes the process more cost-efficient
- Customization:
NovoPower is a customizable blend. This means this blend of tablet manufacturing excipients can be tailored to the specific API, formulation type, and performance requirements of each customer. This even further simplifies the hassle involved in the manufacturing process.
Conclusion:
With pharma moving towards leaner operations and faster time-to-market, process simplification is a must. Novo Excipients, a leading excipient manufacturer in India have constantly been innovating according to the needs of the customer. NovoPower is engineered to make manufacturing smoother, more predictable, and stress-free.
Connect with the Novoexcipients Team to experience the difference in tablet manufacturing with NovoPower.